https://www.selleckchem.com/products/eft-508.html
Using conditioned media and co-culture experiments we found increased osteocyte-induced osteoclastogenesis and bone resorption in estrogen deficient conditions. This is the first study to report that administration of Scl-Ab has the ability to revert osteocyte-mediated osteoclastogenesis and resorption by decreasing RANKL/OPG ratio expression and increasing WISP1 expression in estrogen deficient osteocytes. This study provides an enhanced understanding of the biological changes underpinning decreases in bone resorption following Scl-Ab
Like
Comment
Share
